A 2-year-old child with known β-thalassemia major on regular transfusions presents with progressive hepatomegaly and elevated liver enzymes. The clinician suspects secondary hemochromatosis. Which investigation is most specific for quantifying hepatic iron overload and guiding chelation therapy?

Question

Accepted Answer

B. Magnetic resonance imaging (MRI) T2* of the liver. ## Quantifying Hepatic Iron Overload in Thalassemia

### MRI T2* as the Gold Standard

**Key Point:** MRI T2* (T2-star) is the non-invasive, quantitative gold standard for measuring hepatic iron concentration and guiding iron chelation therapy. T2* values directly correlate with hepatic iron content and predict the risk of cirrhosis and hepatic dysfunction.

### Why MRI T2* is Superior

**High-Yield:** 
- **Non-invasive**: No biopsy required
- **Quantitative**: Directly measures iron concentration in liver tissue
- **Reproducible**: Serial measurements track response to chelation
- **Prognostic**: T2* <6.3 milliseconds indicates significant iron overload and increased cirrhosis risk
- **Organ-specific**: Can assess iron in heart, pancreas, and pituitary simultaneously

### MRI T2* Interpretation

| T2* Value (ms) | Iron Load | Clinical Significance |
|---|---|---|
| >11 | Normal | No iron overload |
| 6.3–11 | Mild-moderate | Requires monitoring |
| <6.3 | Severe | High risk of cirrhosis; aggressive chelation needed |

**Clinical Pearl:** MRI T2* has largely replaced liver biopsy for iron quantification because it is non-invasive, provides quantitative data, and can be repeated serially to assess chelation efficacy.

### Why Other Investigations Fall Short

| Investigation | Limitation |
|---|---|
| **Serum ferritin** | Reflects total body iron but not organ-specific iron; affected by inflammation, infection, and transfusion timing |
| **Transferrin saturation** | Measures circulating iron, not tissue iron; poor correlation with hepatic iron |
| **Liver biopsy** | Invasive; sampling error; Prussian blue staining is qualitative, not quantitative |
| **Serum iron + TIBC** | Measures circulating iron only; does not reflect hepatic iron deposition |

**Warning:** Do not confuse serum ferritin (a surrogate marker of total iron burden) with direct tissue iron quantification. Ferritin can be falsely elevated in inflammation and infection, leading to over- or under-treatment.

### Clinical Application

**Mnemonic:** **MRI T2* = Tissue Iron Quantification**
- Used to initiate chelation therapy
- Used to assess response to chelation
- Used to predict complications (cirrhosis, heart failure)
- Recommended annually in transfusion-dependent thalassemia

Answer

A. Serum iron and total iron-binding capacity

Answer

C. Liver biopsy with Prussian blue staining

Answer

D. Serum ferritin and transferrin saturation

A 2-year-old child with known β-thalassemia major on regular transfusions presents with progressive hepatomegaly and elevated liver enzymes. The clinician suspects secondary hemochromatosis. Which investigation is most specific for quantifying hepatic iron overload and guiding chelation therapy?

Explanation

Quantifying Hepatic Iron Overload in Thalassemia

MRI T2* as the Gold Standard

Why MRI T2* is Superior

MRI T2* Interpretation

Why Other Investigations Fall Short

Clinical Application

Practice similar questions

Join our NEET PG community

T2* Value (ms)	Iron Load	Clinical Significance
>11	Normal	No iron overload
6.3–11	Mild-moderate	Requires monitoring
<6.3	Severe	High risk of cirrhosis; aggressive chelation needed

Investigation	Limitation
Serum ferritin	Reflects total body iron but not organ-specific iron; affected by inflammation, infection, and transfusion timing
Transferrin saturation	Measures circulating iron, not tissue iron; poor correlation with hepatic iron
Liver biopsy	Invasive; sampling error; Prussian blue staining is qualitative, not quantitative
Serum iron + TIBC	Measures circulating iron only; does not reflect hepatic iron deposition